Contents

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Role and responsibilities of the sponsor 

Role and responsibilities of the sponsor
Chapter:
Role and responsibilities of the sponsor
DOI:
10.1093/med/9780199608478.003.0012
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 22 January 2021

This chapter discusses the definitions of a clinical trial sponsor and the roles and responsibilities that it comprises. The aim is to give an overall picture of the role and legal responsibilities and to focus on the systems required for successfully undertaking the role of sponsor. The sponsor is critical, as without a sponsor, a study may not proceed. Sponsor responsibilities are very broad, encompassing overall responsibility for many different trial related activities. These are detailed in GCP guidelines, the EU Directives, the EU Regulation and national regulations. Key areas include authorisations/approvals (including indemnity, insurance and compensation arrangements), financing of the study, conduct of the study to GCP standards, provision of quality systems including SOPs and auditing, manufacture and provision of investigational medicinal product and safety information. Sponsors will therefore require systems to cover these key areas. While activities may be delegated, the sponsor retains overall responsibility, so adequate oversight is required to ensure that these activities are completed to appropriate standards.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.